Cilfa Opposition, Risedronate / Edta, (Ar098686 A2)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, ácido hialurónico, (AR098201A1)
Countries: Argentina Date: 2016
-
CILFA opposition, bempedoic acid, (AR114396A1)
Countries: Argentina Date: 2020
-
CILFA opposition, clodronic acid, (AR110319A1)
Countries: Argentina Date: 2019
-
CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)
Countries: Argentina Date: 2002
-
CILFA opposition, amino acids, (AR110548A1)
Countries: Argentina Date: 2019
-
CILFA opposition, omega-3 polyunsaturated acids, (AR110450A1)
Countries: Argentina Date: 2019
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098982A1)
Countries: Argentina Date: 2016
-
CILFA opposition, MELOXICAM, (AR100293A2)
Countries: Argentina Date: 2016
-
CILFA opposition, Aclidinium, (AR095705A1)
Countries: Argentina Date: 2016
-
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098983A1)
Countries: Argentina Date: 2016